ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "Disease Activity"

  • Abstract Number: 2589 • 2015 ACR/ARHP Annual Meeting

    Associations Between 49 Susceptibility SNPs and Disease Activity Including Radiographic Damage in Early Untreated Rheumatoid Arthritis

    Christian G. Ammitzbøll1, Rudi Steffensen2, Martin Bøgsted3,4, Kaspar Rene Nielsen2, Torkell Ellingsen5, Merete Lund Hetland6, Peter Junker5, Jan Pødenphant7, Mikkel Østergaard8, Julia Johansen9, Kim Hørslev-Petersen10 and Kristian Stengaard-Pedersen1, 1Department of Rheumatology, Aarhus University Hospital, Aarhus, Denmark, 2Department of Clinical Immunology, Aalborg University Hospital, Aalborg, Denmark, 3Department of Haematology, Aalborg University Hospital, Aalborg, Denmark, 4Department of Mathematical Sciences, Aalborg University, Aalborg, Denmark, Aalborg, Denmark, 5Department of Rheumatology, Odense University Hospital, Odense, Denmark, 6DANBIO, Center for Rheumatology and Spine Diseases, Rigshospitalet, Glostrup, Glostrup, Denmark, 7Department of Rheumatology, Copenhagen University Hospital at Gentofte, Glostrup, Denmark, 8Rigshospitalet-Glostrup, Copenhagen Center for Arthritis Research, Center for Rheumatology and Spine Diseases, Rigshospitalet - Glostrup, Glostrup, Denmark, 9Departments of Medicine and Oncology, Copenhagen University Hospital at Herlev, Copenhagen, Denmark, 10Rheumatology, Research Unit at King Christian X Hospital for Rheumatic Diseases, Graasten, Graasten, Denmark

    Background/Purpose: Genome-wide association studies (GWAS) and meta-GWAS studies have identified >50 single nucleotide-polymorphisms (SNPs) that are associated with susceptibility to rheumatoid arthritis (RA). It is,…
  • Abstract Number: 2675 • 2015 ACR/ARHP Annual Meeting

    Has the Relationship Between Disease Activity and Disability in Rheumatoid Arthritis Changed?

    Aneela Mian1, Fowzia Ibrahim2,3, Ian C. Scott4, Sardar Bahadur5, Maria Filkova6, Louise Pollard7, Gabrielle H. Kingsley8, Sophia Steer9, David L. Scott6 and James Galloway10, 1Academic Rheumatology, King's College London, London, United Kingdom, 2Academic Rheumatology Dept, King's College, London, United Kingdom, 3Academic Rheumatology Dept, King's College London, London, United Kingdom, 4Louise Coote Lupus Unit, St Thomas' Hospital, London, United Kingdom, 5Guys' and St Thomas' NHS Trust, London, United Kingdom, 6Academic Department of Rheumatology, King´s College London, London, United Kingdom, 7University Hospital Lewisham, London, United Kingdom, 8Rheumatology, Kings College London, London, United Kingdom, 9Rheumatology Dept, Kings College Hospital, London, United Kingdom, 10King's College Hospital, London, United Kingdom

    Background/Purpose: Rheumatoid arthritis (RA) management paradigms have changed over the last two decades. Evidence now supports aggressive immunosuppression with early use of combination disease modifying…
  • Abstract Number: 3080 • 2015 ACR/ARHP Annual Meeting

    Histone H2AX Phosphorylation As a Measure of DNA Double Strand Breaks and a Marker of Environmental Stress and Disease Activity in Lupus

    Rajaie Namas, Paul Renauer, Mikhail Ognenovski, Pei-Suen Tsou and Amr H. Sawalha, Division of Rheumatology, University of Michigan, Ann Arbor, MI

    Background/Purpose: Studies suggested that defective or inefficient DNA double strand break (DSB) repair results in failure to preserve genomic integrity leading to apoptotic cell death,…
  • Abstract Number: 46 • 2015 ACR/ARHP Annual Meeting

    Feasibility Study of Smartphone Data Collection for Cloudy with a Chance of Pain: Sustained Engagement for Daily Self-Reporting of Disease Severity in Rheumatoid Arthritis over Two Months

    Samuel Reade1, Jamie C Sergeant2,3, Matthew Sperrin4, David M. Schultz5, Karen Spencer6, Caroline Sanders6 and William G Dixon7, 1The University of Manchester, Manchester, United Kingdom, 2NIHR Manchester Musculoskeletal Biomedical Research Unit, Manchester, United Kingdom, 3Arthritis Research UK Centre for Epidemiology, Centre for Musculoskeletal Research, Manchester Academic Health Science Centre, University of Manchester, Manchester, United Kingdom, 4Institute of Population Health, Health e-Research Centre, The University of Manchester, Manchester, United Kingdom, 5Faculty of Engineering and Physical Sciences, School of Earth, Atmospheric and Environmental Sciences, The University of Manchester, Manchester, United Kingdom, 6Institute of Population Health, Centre for Primary Care, The University of Manchester, Manchester, United Kingdom, 7Manchester Academic Health Sciences Centre, Arthritis Research UK Centre for Epidemiology, The University of Manchester, Manchester, United Kingdom

    Background/Purpose: Previous research has attempted to study the association between weather and joint pain. Inconclusive results may be due, in part, to infrequent measures of…
  • Abstract Number: 172 • 2015 ACR/ARHP Annual Meeting

    Prospective Assessment of Carotid Intima Media Thickness in Relation to Activity of the Disease in Patients with Rheumatoid Arthritis

    Bozena Targonska-Stepniak1, Mariusz Piotrowski1, Robert Zwolak2 and Maria Majdan3, 1Rheumatology and Connective Tissue Diseases, Medical University of Lublin, Poland, Lublin, Poland, 2Rheumatologyand Connective Tissue Diseases, Medical University of Lublin, Lublin, Poland, 3Department of Rheumatology and Connective Tissue Diseases, Medical University in Lublin, Poland, Lublin, Poland

    Background/Purpose: Rheumatoid arthritis (RA) is a chronic, inflammatory disease that is complicated by accelerated atherosclerosis associated with the risk of adverse cardiovascular (CV) events and…
  • Abstract Number: 541 • 2015 ACR/ARHP Annual Meeting

    Microrna-125b Expression in PBMCs Is Associated with Disease Activity in Patients with Early Rheumatoid Arthritis

    Veronika Hruskova1,2, Romana Jandová3, Lucia Vernerova4, Herman F Mann5, Klára Prajzlerová4, Maria Filkova4, Karel Pavelka5, Jiri Vencovsky5 and Ladislav Senolt5, 1Institute of Rheumatology and Department of Rheumatology; Faculty of Science Charles University, Prague, Czech Republic, 2Faculty of Science, Charles University, Prague, Czech Republic, 3Institute of Rheumatology and Department of Rheumatology, Prague, Czech Republic, 4Institute of Rheumatology and Department of Rheumatology, 1st Faculty of Medicine, Charles University, Prague, Czech Republic, 5Institute of Rheumatology and Department of Rheumatology, 1st Faculty of Medicine, Charles University, Prague, Czech Republic, Prague, Czech Republic

    Background/Purpose: MicroRNAs (miRNAs) are small non-coding RNAs that function as negative regulators of gene expression at posttranscription level and play a significant role in rheumatoid…
  • Abstract Number: 771 • 2015 ACR/ARHP Annual Meeting

    Convergent Validity of New Disease Assessment Instruments in Systemic Lupus Erythematosus in Relation to Sledai-2K

    Christopher Collins1, W. Winn Chatham2, Howard Busch3, Norman B. Gaylis4, Emily Hautamaki5 and Siva Narayanan6, 1MedStar Washington Hospital Center, Washington, DC, 2Medicine/Clinical Immunology and Rheumatology, University of Alabama at Birmingham, Birmingham, AL, 3Science & Research Institute, Jupiter, FL, 4Arthritis & Rheumatic Disease Specialties, Aventura, FL, 5Ipsos Healthcare, Washington, DC, 6Global Evidence, Value and Access, Ipsos Healthcare, Washington, DC

    Background/Purpose: Current validated disease assessment instruments (DAIs) in systemic lupus erythematosus (SLE) such as SLEDAI-2K and BILAG, require disease expertise and/or involve complex scoring systems,…
  • Abstract Number: 1579 • 2015 ACR/ARHP Annual Meeting

    Association of Myocardial Abnormalities with N-Terminal Pro-Brain Natriuretic Peptide and Disease Activity in Rheumatoid Arthritis without Cardiac Symptoms, Assessed By Cardiac Magnetic Resonance Imaging

    Hitomi Kobayashi1, Yasuyuki Kobayashi2, Isamu Yokoe3, Natsumi Ikumi4,5, Hirotake Inomata6, Atsuma Nishiwaki6, Noboru Kitamura1, Kaita Sugiyama6, Hidetake Shiraiwa6, Masataka Nozaki6, Yosuke Nagasawa6, Yoshihiro Matsukawa5 and Masami Takei1, 1Division of Hematology and Rheumatology, Nihon University School of Medicine, Tokyo, Japan, 2Advanced Biomedical Imaging Informatics, St.Marianna University School of Medicine, Kawasaki, Japan, 3Rheumatology, Itabashi Chuo Medical Center, Tokyo, Japan, 4Nihon University School of Medicine, Shinjuku, Japan, 5Division of Heamatology and Rheumatology, Nihon University School of Medicine, Tokyo, Japan, 6Nihon University School of Medicine, Tokyo, Japan

    Background/Purpose: Rheumatoid arthritis (RA) is a multi-organ inflammatory disorder associated with high cardiovascular morbidity and mortality. Cardiac involvements are typically clinically silent, only manifesting as…
  • Abstract Number: 2285 • 2015 ACR/ARHP Annual Meeting

    Poor Quality of Sleep Is Associated with Increased Disease Activity and Fatigue in Axial Spondyloarthritis

    Lana Frost1, Jiayi Zhou2, Lourdes Pena Castillo2, Sean Hamilton1, Nayef Al Ghanim1, Proton Rahman1 and Jennifer Burt1, 1Rheumatology, St. Clare's Mercy Hospital, St. John's, NF, Canada, 2Computer Science, Memorial University of Newfoundland, St. John's, NF, Canada

    Background/Purpose: Sleep disturbance is a common occurrence in musculoskeletal disease including ankylosing spondylitis. The reasons for the sleep disturbance in rheumatic diseases are multifactorial. There…
  • Abstract Number: 2601 • 2015 ACR/ARHP Annual Meeting

    The Multi-Biomarker Disease Activity Score in a TNF Inhibitor Tapering Study in Rheumatoid Arthritis Patients: Predictive Value for Successful Tapering, Flaring and Radiographic Progression

    Chantal A.M. Bouman1, Aatke van der Maas1, Noortje van Herwaarden1, Eric H. Sasso2, Frank H.J. van den Hoogen1 and Alfons A. den Broeder1, 1Rheumatology, Sint Maartenskliniek, Nijmegen, Netherlands, 2Crescendo Bioscience Inc., South San Francisco, CA

    Background/Purpose: We evaluated the predictive value of the multi-biomarker disease activity (MBDA) score for clinical outcomes and radiographic progression in a TNFi tapering study in…
  • Abstract Number: 2682 • 2015 ACR/ARHP Annual Meeting

    A Brief Patient-Reported Measure of Physical Function Is Sensitive to Changes in a Composite Disease Activity Measure in a Diverse Rheumatoid Arthritis Clinic Setting

    Elizabeth R. Wahl1,2, Andrew Gross2, Vladimir Chernitskiy2, Laura Trupin2, Jinoos Yazdany3 and Patricia P. Katz2, 1Medicine/Rheumatology, San Francisco Veterans Affairs Medical Center, San Francisco, CA, 2Medicine/Rheumatology, University of California San Francisco, San Francisco, CA, 3University of California, San Francisco, San Francisco, CA

    Background/Purpose: Rheumatoid arthritis (RA) patients' physical function is a strong predictor of clinical outcomes. A brief patient-reported measure of physical function, the PROMIS PF-10a (PF-10a),…
  • Abstract Number: 3118 • 2015 ACR/ARHP Annual Meeting

    Clinical Characteristics and Disease Outcomes in Psoriatic Arthritis Patients By Extent of Body Surface Area Affected By Psoriasis: Results from Corrona Registry

    Philip J. Mease1,2,3,4, Chitra Karki5, Carol J. Etzel5,6, Arthur Kavanaugh7, Christopher T. Ritchlin8, Wendi Malley5, Vivian Herrera9, Jacqueline B. Palmer9 and Jeffrey D. Greenberg5,10, 1Swedish Medical Center and University of Washington School of Medicine, Seattle, WA, 2Seattle Rheumatology Associates, Seattle, WA, 3Rheumatology Research, Swedish Medical Center, Seattle, WA, 4Clinical Professor, University of Washington School of Medicine, Seattle, WA, 5Corrona, LLC, Southborough, MA, 6University of Texas M.D. Anderson Cancer Center, Houston, TX, 7University of California San Diego, La Jolla, CA, 8Allergy, Immunology and Rheumatololgy Division, University of Rochester Medical Center, Rochester, NY, 9Novartis Pharmaceuticals Corporation, East Hanover, NJ, 10NYU School of Medicine, New York, NY

    Background/Purpose: Psoriatic arthritis (PsA) is a type of inflammatory arthritis that is commonly comorbid with the skin condition, psoriasis. A major contributor to the severity…
  • Abstract Number: 217 • 2015 ACR/ARHP Annual Meeting

    Circulating Levels of Neo-Epitopes Reflecting Connective Tissue Turnover As Biomarkers of Gout and Frequent Gout Attacks in Men

    Ana Valdes1, Tina Manon-Jensen2, Wendy Jenkins3, Anne Sofie Siebuhr4, Morten Asser Karsdal4, Sally Doherty5, Abhishek Abhishek3, Helen Richardson3, Weiya Zhang6, Michael Doherty7 and Anne C. Bay-Jensen8, 1Division of Rheumatology, Orthopaedics and Dermatology, University of Nottingham, Nottingham, United Kingdom, 2Antibody Research Unit, Nordic Bioscience, 2370, Denmark, 3Devision of Rheumatology, University of Nottingham, NG5 1PB, England, 4Biomarkers and Research, Nordic Bioscience, Herlev, Denmark, 5Division of ROD, University of Nottingham, Nottingham, United Kingdom, 6Academic Rheumatology, School of Clinical Sciences, University of Nottingham, Nottingham, United Kingdom, 7Academic Rheumatology, City Hospital, Nottingham, United Kingdom, 8Biomarkers and Research, Rheumatology, Nordic Bioscience, Herlev, Denmark

    Background/Purpose: Recurrent flares constitute the main clinical burden of gout. The neo-epitope blood-based biomarkers, C1M and C3M, measuring matrix metalloproteinases (MMP)-mediated connective tissue degradation, have previously…
  • Abstract Number: 561 • 2015 ACR/ARHP Annual Meeting

    Improvement in Disease Activity and the Long-Term Risk of Serious Infectious Events in Rheumatoid Arthritis Patients Treated with Certolizumab Pegol

    Jeffrey R. Curtis1, Marc de Longueville2, Cathy O'Brien2 and Boulos Haraoui3, 1University of Alabama at Birmingham, Birmingham, AL, 2UCB Pharma, Brussels, Belgium, 3Department of Medicine, Centre Hospitalier de l'Université de Montréal, Montréal, QC, Canada

    Background/Purpose: Anti-TNF drugs are an effective treatment option for rheumatoid arthritis (RA) patients (pts) but have been associated with an increased incidence of serious infectious…
  • Abstract Number: 785 • 2015 ACR/ARHP Annual Meeting

    Further Validation of Simple Index As a Simple Disease Activity Assessment Tool for SLE

    Nisarg Gandhi1, Meenakshi Jolly2, Alana Nevares3 and Winston Sequeira1, 1Rheumatology, Rush University Medical Center, Chicago, IL, 2Department of Medicine, Section of Rheumatology, Rush University Medical Center, Chicago, IL, 3Internal Medicine, Cook County Hospital, Chicago, IL

    Background/Purpose: An easy, quick tool, requiring minimal training or physician input for disease activity (DA) assessment in SLE, would have potentially greater uptake for routine…
  • « Previous Page
  • 1
  • …
  • 81
  • 82
  • 83
  • 84
  • 85
  • …
  • 102
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology